QualityStocksNewsBreaks Archives - Page 913 of 1392

ThursdayApr 23, 2020 11:38 am

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Announces Sharp Expansion in Production Capacity at the Farm

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that it has increased the total cannabis production capacity at NUGS Farm (the “Farm”) by 88% to 150% as a result of recent management decisions and production upgrades. According to the update, the company expects to produce between 1,500 pounds and 2,000 pounds of cannabis product over the next 45-60 days, and similar amounts of product over subsequent 45-60 day periods. “We have sharply expanded our production capacity to take advantage of an extremely advantageous context,” Cannabis Strategic Ventures CEO Simon Yu said in the…

ThursdayApr 23, 2020 10:19 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Commences Trading on the OTCQB Venture Market

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares have graduated from the OTC Pink Open Market to the OTCQB Venture Market (the “OTCQB”), a U.S. trading platform operated by the OTC Markets Group. Effective immediately, Champignon Brands will commence trading on the OTCQB under the ticker symbol “SHRMF.” Champignon’s common shares will continue to trade under the ticker symbol “SHRM” on the Canadian Securities Exchange as…

ThursdayApr 23, 2020 10:10 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Notice of Allowance for New Patent, Issuance of Stock Options Under Equity Incentive Plan

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its receipt of a Notice of Allowance from the United States Patent and Trademark Office ("USPTO") for a new patent. According to the update, the new patent provides additional claims that protect the use of its DehydraTECH(TM) technology together with cannabinoids, nicotine, nonsteroidal anti-inflammatory drugs, or vitamins in mix and serve beverage formats. This patent, with application number 16/497,920 under the title "Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof," signifies another addition to Lexaria's first patent family, under…

ThursdayApr 23, 2020 9:21 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Executes Agreement to Exchange $2.1M Debt for Equity

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Wednesday announced that it has entered into an exchange agreement with POAI chief executive officer Dr. Carl Schwartz regarding a $2.1 million promissory note of the company. Per the agreement, Dr. Schwartz has exchanged the note for 1,533,481 shares of newly issued common stock at an exchange rate of $1.43 each, the closing price of the common stock on April 21, 2020. Dr. Schwartz agreed to not sell or transfer 766,740 shares (one-half of the shares) for three months after…

WednesdayApr 22, 2020 12:06 pm

QualityStocksNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Forms Advanced Strategic Collaboration with Tencent IBG

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it has formed an advanced strategic collaboration with Tencent International Business Group (“Tencent IBG”), a leading provider of Internet value added services in China. Per the update, the collaboration will unify iClick's strong multinational clients' coverage worldwide and Tencent IBG's advertising technology to deliver customized and premium digital marketing solutions to international advertisers. “iClick is thrilled to announce this new collaboration, another milestone in our long-term relationship with Tencent IBG, which covers all of Tencent IBG's clients outside China,” iClick's…

WednesdayApr 22, 2020 11:15 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO Discusses Distinctive Business Model in Exclusive Interview

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that its director and CEO Dr. Carl Schwartz was featured in an exclusive interview with NetworkNewsWire (“NNW”). In the interview, Dr. Schwartz discussed Predictive Oncology’s distinctive business model, as well as significant changes management is making to position the company for the future. “Predictive’s major asset is its Helomics subsidiary and its proprietary database of over 150,000 cancer tumors covering over 137 types of cancers, with over 30,000 tumors related to ovarian cancer, which is sort of our specialty.…

WednesdayApr 22, 2020 11:03 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Continued Progress Amidst COVID-19

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today provided an update on its operational and financial measures in response to the COVID-19 pandemic. According to the update, the company and its wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., are fully maintaining business activities as usual, with minimal impact to research and development, business development and marketing. In response to the COVID-19 outbreak and its financial implications, Foresight took decisive action to reduce its monthly cash burn spending by more than 20%. The company is pleased with its technological development progress and…

WednesdayApr 22, 2020 10:21 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Management Featured in Cleantech and Climate Change Podcast – Earth Day Interview

SinglePoint (OTCQB: SING) today announced that its President and Director William Ralston and Chief Financial Officer Corey A. Lambrecht were featured in a Cleantech and Climate Change Podcast - Earth Day Interview. According to the update, Investorideas.com, a global news source and leading investor resource covering cleantech and renewable energy stocks (Renewableenergystocks.com) issued the Earth Day special edition of the podcast. In the interview, SinglePoint management discuss the future of solar and the scalability and adaptability of SING’s Direct Solar subsidiary. “With what is going on in the global market and with the pandemic, it's a world imagining where we…

WednesdayApr 22, 2020 10:13 am

QualityStocksNewsBreaks – Cannabis Global, Inc. (MCTC) and Sugarmade, Inc.’s (SGMD) BudCars Enter License Agreement for Production of Super-Premium Edibles for the California Marketplace

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced the licensing of several patent-pending technologies to Sugarmade’s (OTCQB: SGMD) Sacramento-based BudCars Cannabis Delivery Service for use in cannabis edibles for the regulated California marketplace. Under the agreement, Cannabis Global will license its unique cannabinoid infusion technologies to BudCars for the production of super-premium, highly bioavailable cannabis edibles. “We have developed and have pending patents on several technologies that not only make the production of cannabis edibles less expensive but also improve product quality. While we are rolling out our own…

WednesdayApr 22, 2020 9:25 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Research Partner Secures Steady Psilocybin Supply for Clinical Studies

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company that is advancing its clinical pipeline through its ongoing TBI/PTSD-focused preclinical studies at the University of Miami’s Miller School of Medicine, today announced that its research partner and lead investigator, Dr. Michael Hoffer, has obtained a sustainable supply of psilocybin under a DEA schedule I license, which will be used for ongoing psilocybin-based therapeutics studies. Under a collaborative research agreement with the University of Miami's Miller School of Medicine, Champignon’s wholly owned subsidiary, Tassili Life Sciences Corp., is conducting preclinical studies and eventual human clinical trials, with…

Site Search

Company Search

Category: QualityStocksNewsBreaks